Nov 3, 2024 LaunchPort is pleased to announce that Nanochon (https://www.nanochon.com/) has joined their City Garage/Baltimore Peninsula location as a LaunchPort Resident.Nanochon’s mission is to develop a new approach to treat cartilage replacement and repair so that the hundreds of thousands of young, active patients with knee damage can return to their lifestyles without having to undergo costly and invasive short-term fixes. Founded in 2016, their technology is a minimally-invasive early intervention that could help avert the need for total knee replacement. Nanochon’s Chondrograft device is a sturdy medical advancement that is one part orthopedic load-bearing implant, one part tissue growth scaffold, and completely revolutionary. Their implant replaces lost or damaged cartilage and encourages new growth using innovative nanomaterial and 3-D printed designs. This technology has the potential to provide a more successful, faster, longer-lasting, and more affordable solution to joint disease and injury.
Nanochon’s CEO Ben Holmes commented “Over the last three years, Nanochon has gained a tremendous amount of benefit, strategic support and R&D resources from JLABS@DC. As we have grown, our objectives and needs have changed; we now need expertise, physical space and new resources to support clinical and commercial production of our implant for cartilage repair in joints. That is why we have chosen to expand our operations at The LaunchPort. We are excited to build up clinically viable and high quality production to support our future randomized clinical trials, and commercial launch of the product.”
Nanochon is expected to be a key element of LaunchPort’s strategy to expand partnerships and capabilities in additive and advanced medtech manufacturing within the State.